PreprintAll rights reservedbioRxiv
An adjuvant for in vivo CAR-T therapy potentiation against solid tumors
- 1Institute of Process Engineering, Chinese Academy of Sciences
Related
- A 3D microfluidic model for preclinical evaluation of TCR-engineered T cells against solid tumors
- 840 Cleavable albumin-hitchhiking STING agonists for innate immune activation and combination with adoptive cell therapy in solid tumors
- CXCR3 on transferred T cells enables vaccine-boosted adoptive T-cell therapy in solid tumors
- 556 A phase I first-in-human trial of IL-12 genetically engineered myeloid cells in participants with relapsed, refractory solid tumors
- 563 Updated safety and efficacy of AN4005, an oral small-molecule PD-L1 inhibitor, in advanced solid tumors: phase I dose-escalation and expansion
BibTeX
@misc{sun2026adjuvant,
title = {{An adjuvant for in vivo CAR-T therapy potentiation against solid tumors}},
author = {Y. Sun and Y. Ma and T. Guan and Y. Yan and Y. Ming and X. Huang and Y. Luo and J. Cai and G. Ma and F. You and M. Qiu and J. Chen and Y. Xia},
howpublished = {bioRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.30.763005},
url = {https://www.biorxiv.org/content/10.64898/2026.10.30.763005v1},
}
RIS
TY - UNPB
TI - An adjuvant for in vivo CAR-T therapy potentiation against solid tumors
AU - Y. Sun
AU - Y. Ma
AU - T. Guan
AU - Y. Yan
AU - Y. Ming
AU - X. Huang
AU - Y. Luo
AU - J. Cai
AU - G. Ma
AU - F. You
AU - M. Qiu
AU - J. Chen
AU - Y. Xia
PY - 2026
DA - 2026/10/30
PB - bioRxiv
DO - 10.64898/2026.10.30.763005
UR - https://www.biorxiv.org/content/10.64898/2026.10.30.763005v1
ER -